Root is cheap and could be a better buy than Lemonade here, because it is proving it can grow and make money at the same time. It picked the difficult personal auto market and executed exceptionally, with underwriting improving quarter after quarter and capital-efficient scaling showing up as high ROIC. The market will likely reward that. The choice versus Lemonade, which is building a long-term insurance brand, remains nuanced and depends on what an investor wants. x.com 

Lemonade's profitability problem outweighs its impressive growth. Revenue rose from $23 million in 2018 to $975 million over the last 12 months, a 65% CAGR, and members nearly tripled since 2021. Yet the capital-light insurtech still guides to negative 2026 EBITDA, below its initial expectations, and after 11 years is not close to positive EBITDA. Management has been less transparent about cutting costs. Solving profitability could make it a home run; Root's management is preferred. x.com  x.com  … Show more

Root looks expensive at 16x next year's earnings when insurers usually get 12x. Fair value is about $29.78-37.90, or 12x next year's expected $2.82 EPS give or take 12%, so the stock trades about 22% above the top of that range. The view rests on reported earnings and estimates only, with no fundamental work. x.com 

Lemonade is reducing transparency on a key indicator of whether it can scale efficiently. Earnings reports once showed in-force premium versus opex, then switched to premium versus employee count, presumably as opex rose, and now show premium alone. Investors are tiring of waiting for EBITDA profitability, and the missing comparative metrics give less insight into how Lemonade gets there. The stock had run ahead into earnings, so a reset was due without a blowout. x.com  x.com 

Lemonade looks expensive once valued as what it is, an insurance company. Replying to @javierluraschi's post on the stock, any price above 1x revenue is expensive for an insurer. x.com 

Self-driving cars give Root and Lemonade no edge, because if accidents fall, everyone benefits and insurers charge less, so the whole auto insurance industry shrinks. On the surface the risk looks like self-driving's threat to Uber, but the mechanics are completely different, and insurance companies are not attractive to own in general. The view is offered tentatively, as a non-expert. x.com  x.com 

Lemonade's share-price drop after a great second quarter is a wild overreaction. Per its Q2 2026 results, in-force premium rose 32.4% to $1.43 billion and revenue grew 79% to $294 million, the 11th straight quarter of accelerating growth, with over 3.3 million customers. x.com  x.com 

Lemonade looks good but not good enough after a lofty price and high expectations into earnings, so it needs to get cheaper before it is worth buying. In-force premium grew 32% and revenue 79% as it approaches positive cash flow by the end of 2026; the low $40s or $30s would be the level to buy more. x.com  x.com 

Lemonade is a monster stock in the making after a massive quarter. Per co-founder @shai_wininger, in-force premium grew 32% to $1.33 billion, the 10th straight quarter of acceleration, revenue rose 71% to $258M and gross profit 159% to $100M, with $17M of adjusted free cash flow. Pet passed $500M of premium, car grew 60% with its loss ratio down 14 points to 74%, and Lemonade raised 2026 guidance, targeting positive adjusted EBITDA in Q4. x.com 

Bowhead Specialty is the quality winner over Lemonade, outperforming it on every metric at a fraction of the size. Both grow at the same year-over-year rate, but Bowhead is more profitable, has 3.57% short interest versus Lemonade's 21%, and is worth slightly under $1B against Lemonade's nearly $6B. Lemonade has fallen to about half its $80 level, a reminder that quality beats influencer-driven meme stocks. x.com